Apo Asset Management (apoAsset) is taking a stake in the investment fund boutique Medical Strategy. The fund specialist apoAsset, which belongs to the Deutsche Apotheker- und Ärztebank, a provider of banking products and services for the healthcare sector in Germany, and Deutsche Ärzteversicherung, which offers insurance services to doctors in Germany, is acquiring a 25.1% stake in the company. This will create the largest German specialist network for global healthcare funds, with more than 20 fund managers, scientific advisors and market analysts. Medical Strategy will remain an independent company with regard to both its investment philosophy and its management.
For further details please click here
Juni 2017: Dr. Jörg Blumentrath strengthens Medical Strategy
detailed report: MP Dr. Jörg Blumentrath